Charles V Olson

Title: Charles V Olson: Innovator in Pharmaceutical Compositions

Introduction

Charles V Olson is a notable inventor based in Moraga, CA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on innovative compositions and methods that enhance the efficacy of pharmaceutical treatments.

Latest Patents

One of Olson's latest patents is titled "Pharmaceutical compositions comprising FGF19 variants." This patent provides pharmaceutical compositions, formulations, and dosage forms that include variants of fibroblast growth factor 19 (FGF19) proteins and peptide sequences. It also covers fusions of FGF19 and/or fibroblast growth factor 21 (FGF21) proteins, along with methods of using these compositions. Another significant patent is "Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration." This patent discloses a cell culture medium that is low in dissolved carbon dioxide, containing less than about 1 g/L added sodium bicarbonate, and includes an organic buffer and a metal complexing agent.

Career Highlights

Throughout his career, Charles V Olson has worked with prominent companies such as Bayer Corporation and NGM Biopharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Olson has collaborated with notable professionals in his field, including Michael Zachariou and Ricaredo Matanguihan. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Charles V Olson is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact medical treatments significantly. His innovative patents and collaborations reflect his commitment to advancing the field of pharmaceuticals.